Povidone iodine as a low cost therapeutic against the SARS-CoV-2 virus and its potential for refugee health
- Journal of Human Virology & Retrovirology
Cameron L Jones1,2,3
This review summarizes one approach to support the health needs of refugee and displaced asylum seeker migrant populations during the SARS-CoV-2 pandemic. Refugees are the leading abandoned group during pandemic crises and their health needs are always at greater risk. Living conditions are unsettled and there is often limited access to health facilities and to necessary infection control measures to control viral spread. Therefore, access to and provision of economical, safe, and effective antiseptic options must be addressed for better community health and for the reduction of viral transmission. Recent research on povidone-iodine, PVP-I supports its use as a potent, topical virucidal antiseptic against SARS-CoV-2 at the 99% level. This paper summarizes the evidence from both in vitroand in vivoresearch. Generalizing across the studies shows that PVP-1 used as a mouth wash, oral rinse, or a gargle can reduce viral load. Because of its cost-effectiveness and high virucidal activity, PVP-I can be used as an effective self-care antiseptic in the refugee population.
povidone iodine, refugee, therapeutic, SARS-CoV-2, COVID-19, antiseptics